OMISIRGE Trademark

Trademark Overview

On Wednesday, January 22, 2020, a trademark application was filed for OMISIRGE with the United States Patent and Trademark Office. The USPTO has given the OMISIRGE trademark a serial number of 88768530. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Gamida Cell Inc.. The OMISIRGE trademark is filed in the Pharmaceutical Products category with the following description:

Cell therapy preparations for the treatment of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders
omisirge

General Information

Serial Number88768530
Word MarkOMISIRGE
Filing DateWednesday, January 22, 2020
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7207882
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements

Goods and ServicesCell therapy preparations for the treatment of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 25, 2020
Primary Code005
First Use Anywhere DateMonday, September 18, 2023
First Use In Commerce DateMonday, September 18, 2023

Trademark Owner History

Party NameGAMIDA CELL LTD.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressKIRYAT GAT 82584120
IL
Party NameGamida Cell Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameGamida Cell Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameGamida Cell Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Wednesday, March 27, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, September 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 20, 2023USE AMENDMENT FILED
Wednesday, September 20, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023SOU EXTENSION 5 GRANTED
Tuesday, June 20, 2023SOU EXTENSION 5 FILED
Wednesday, June 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 23, 2022SOU EXTENSION 4 GRANTED
Friday, December 23, 2022SOU EXTENSION 4 FILED
Friday, December 23, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 15, 2022SOU EXTENSION 3 GRANTED
Friday, July 15, 2022SOU EXTENSION 3 FILED
Friday, July 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 18, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 18, 2022SOU EXTENSION 2 FILED
Tuesday, January 18, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 9, 2021SOU EXTENSION 1 GRANTED
Friday, July 9, 2021SOU EXTENSION 1 FILED
Friday, July 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 16, 2020EXAMINER'S AMENDMENT ENTERED
Friday, October 16, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 16, 2020EXAMINERS AMENDMENT E-MAILED
Friday, October 16, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, October 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION WRITTEN
Friday, April 10, 2020ASSIGNED TO EXAMINER
Saturday, January 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 25, 2020NEW APPLICATION ENTERED

Related Keywords

omisirge bone marrow diseases disorders blood leukemia preparations hematology oncology field